News and Events

Paris, France and Camberley, UK – 24 May 2019 – Novacyt (EURONEXT GROWTH: ALNOV; AIM: NCYT), an international specialist in clinical diagnostics, today announces that the Company’s Annual Report and Accounts (“Annual Report”) for the year ended 31 December 2018 has been published and uploaded to the Company’s website. The Annual Report will also be

Paris, France and Camberley, UK – 17 May 2019 – Novacyt (EURONEXT GROWTH: ALNOV; AIM: NCYT) an international specialist in clinical diagnostics, announces that, pursuant to the Convertible Bonds with Warrants Funding Programme announced on 23 April 2019, it has issued a tranche of new ordinary shares of €1/15 each (“Ordinary Shares”) to Negma Group

Paris, France et Camberley, UK – 17 mai 2019 – Novacyt (EURONEXT GROWTH: ALNOV; AIM: NCYT), spécialiste international du diagnostic Clinique, annonce qu’en vertu du Programme de Financement par Obligations Convertibles assorties de Warrants annoncé le 23 avril 2019, elle a émis une tranche d’actions ordinaires nouvelles de 1/15 € chacune (« Actions Ordinaires ») à Negma Group